Skip to main content

Embolic Protection Devices Market Research, Diagnostics & Therapeutics Applications Scope by Types

Embolic Protection Devices Market Rise with Increasing prevalence of rate in cardiovascular disorders is likely to drive the growth of the global market at a CAGR of 8.5% during 2018 to 2023
Market Overview
Embolic protection devices are devices used to prevent or reduce plaque debris from reaching the distal bed during surgical procedures. They are commonly used in Saphenous Vein Graft (SVG) interventions and during carotid artery stenting procedures.
The global embolic protection devices market is majorly driven by the high prevalence of cardiovascular diseases, increasing technical advanced devices, increasing demand for minimally invasive procedures, and growing penetration by market players.
Embolic Protection Devices Market Segmentation
The global embolic protection devices market is segmented on the basis of type, material, usage, application, and end-user.
On the basis of type, the market is segmented into distal filter devices, distal occlusion devices, and proximal occlusion devices.
On the basis of material, the market is segmented into nitinol and polyurethane.
On the basis of usage, the market is segmented into disposable devices and reusable devices.
On the basis of application, the market is segmented into cardiovascular diseases, neurovascular diseases, and peripheral vascular diseases.
On the basis of cardiovascular diseases, it is further sub-segmented into coronary artery diseases, trans Cather aortic valve replacement, and saphenous vein graft diseases.
On the basis of the end-user, the market is segmented into hospitals and clinics, specialty centers, and ambulatory surgical centers.
Embolic Protection Devices Market Players
  • Medtronic
  • Abbott Laboratories
  • Boston Scientific
  • Cordis
  • Contego Medical
  • Silk Road Medical
  • Claret Medical
  • Allium Medical Solutions
  • Angioslide
  • Claret Medical
  • Edwards Lifesciences Corporation
LIST OF TABLES
Table 1 Embolic Protection Devices Industry Synopsis, 2018–2023
Table 2 Global Embolic Protection Devices Market Estimates And Forecast, 2018–2023, (USD Million)
Table 3 Global Embolic Protection Devices Market, By Region, 2018–2023, (USD Million)
Table 5 Global Embolic Protection Devices Market, By Type, 2018–2023, (USD Million)
Table 5 Global Embolic Protection Devices Market, By Material, 2018–2023, (USD Million)
Table 6 Global Embolic Protection Devices Market, By Application, 2018–2023, (USD Million)
Table 7 Global Embolic Protection Devices Market, By End-User, 2018–2023, (USD Million)
…To be Continued.
Embolic Protection Devices Market Regional Analysis
The Americas dominates the global embolic protection devices market owing to the increasing aging population, which eventually leads to the increasing patient population. According to the American Heart Association, 31% of the deaths in the U.S. were due to cardiovascular disorders. Similarly, according to the Center for Disease Control and Prevention, in 2015, around USD 3.2 trillion were spend in healthcare expenditure in the U.S.
Europe accounts for the second largest market due to the increasing cardiovascular disorders and increasing obesity rates. Additionally, the increasing government support and increasing healthcare infrastructure along with the rising demand for minimally invasive treatment are driving the growth of the embolic protection devices market in Europe. For instance, Eurostat estimated that over 19.2% of the population in Europe were aged 65 and above.
Asia Pacific is the fastest growing market for the embolic protection devices whose growth is attributed to rising population and increasing standard of living. India and China are the major contributors to the market growth due to the rapid development of healthcare infrastructure in these regions and increasing demand for diagnostic services.
On the other hand, the Middle East and Africa is expected to witness a slow growth due to limited access to healthcare and affordability issues among the population. In the Middle East, the growth of the market is driven by the increasing availability of new and advanced diagnostic and treatment methods for various chronic diseases.
About Market Research Future: we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:
Market Research Future
+1 646 845 9312
Labels:

Comments

Post a Comment

Popular posts from this blog

Hemifacial Spasm Market Application Scope, Types, Technology Benefits and Global Business

  Hemifacial Spasm Market  Research Information: By Diagnosis (Mri, Ct Or Cat Scan, Angiography (Arteriography)), Treatment (Medical Treatment, Surgical Treatment, Combinational Therapy, Tens, Physical Therapy, Others), End User – Global Forecast Till 2023 Market Highlights: Hemifacial spasm is a condition that causes frequent muscle spasms, on one side of the face. The condition can affect both men and women, but it is most prevalent in middle-aged or older women. Its incidence rate is also found to be higher among the Asian population. A number of factors such as increasing technological advancements, rising public awareness, increased incidence of craniofacial tremor, and facial chorea, unmet medical needs, increasing government assistance, improving regulatory framework, increasing adoption rate, and improvement in funding and reimbursement policies are propelling the growth of the global hemifacial spasm market. However, difficult diagnosis, cost of treatment, side-effect...
Post a Comment
Read more

U.S. Uterine Fibroid Market Latest Devices, Key Players Statistics Data, Regional Business Outlook 2022

U.S. Uterine Fibroid Market by Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others), by Diagnosis (Medical Resonance Imaging (MRI) scanners, Computed Tomography (CT), Ultrasounds and others) and Treatment (Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy) - Forecast to 2022 The  US Uterine Fibroid Market  report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives is also available in the report Major Key Players To gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch. These are the Top Market...
Post a Comment
Read more

Global Merkel Cell Carcinoma Market Clincial Assessment and Professional Industry Outlook 2023

  Global Merkel Cell Carcinoma Market  Research Report: By Diagnosis (Physical Examination, Sentinel Node Biopsy, Imaging Test), Treatment (Surgery, Radiation Therapy, Chemotherapy), End User (Hospitals & Clinics, Diagnostic Centers) – Forecast till 2023 Market Highlights Increasing prevalence of Merkel cell carcinoma and growing geriatric population are estimated to be the major drivers for the market growth during the forecast period. Moreover, increasing R&D expenses by the key market players, rising mortality rate by MCC, and growing healthcare expenditure is further boosting the market growth. However, the high cost of therapeutics and related side effects along with the lack of awareness and low per capita healthcare expenditures in the developing economies restrains the market growth.  Intended Audience Pharmaceutical Companies Biotechnological Institutes Government and Private Laboratories Research and Development (R&D) Companies Medical Research Labor...
Post a Comment
Read more